1. Home
  2. VNDA vs MEI Comparison

VNDA vs MEI Comparison

Compare VNDA & MEI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • VNDA
  • MEI
  • Stock Information
  • Founded
  • VNDA 2002
  • MEI 1946
  • Country
  • VNDA United States
  • MEI United States
  • Employees
  • VNDA N/A
  • MEI N/A
  • Industry
  • VNDA Biotechnology: Pharmaceutical Preparations
  • MEI Electrical Products
  • Sector
  • VNDA Health Care
  • MEI Technology
  • Exchange
  • VNDA Nasdaq
  • MEI Nasdaq
  • Market Cap
  • VNDA 289.0M
  • MEI 257.8M
  • IPO Year
  • VNDA 2006
  • MEI N/A
  • Fundamental
  • Price
  • VNDA $5.28
  • MEI $7.48
  • Analyst Decision
  • VNDA Strong Buy
  • MEI Buy
  • Analyst Count
  • VNDA 3
  • MEI 2
  • Target Price
  • VNDA $14.00
  • MEI $11.25
  • AVG Volume (30 Days)
  • VNDA 993.5K
  • MEI 252.5K
  • Earning Date
  • VNDA 10-29-2025
  • MEI 12-03-2025
  • Dividend Yield
  • VNDA N/A
  • MEI 3.77%
  • EPS Growth
  • VNDA N/A
  • MEI N/A
  • EPS
  • VNDA N/A
  • MEI N/A
  • Revenue
  • VNDA $212,074,000.00
  • MEI $1,030,100,000.00
  • Revenue This Year
  • VNDA $14.32
  • MEI N/A
  • Revenue Next Year
  • VNDA $37.05
  • MEI $3.41
  • P/E Ratio
  • VNDA N/A
  • MEI N/A
  • Revenue Growth
  • VNDA 11.12
  • MEI N/A
  • 52 Week Low
  • VNDA $3.81
  • MEI $5.08
  • 52 Week High
  • VNDA $5.70
  • MEI $17.45
  • Technical
  • Relative Strength Index (RSI)
  • VNDA 60.60
  • MEI 59.14
  • Support Level
  • VNDA $4.72
  • MEI $6.51
  • Resistance Level
  • VNDA $5.46
  • MEI $7.33
  • Average True Range (ATR)
  • VNDA 0.24
  • MEI 0.32
  • MACD
  • VNDA 0.09
  • MEI 0.08
  • Stochastic Oscillator
  • VNDA 86.13
  • MEI 90.72

About VNDA Vanda Pharmaceuticals Inc.

Vanda Pharmaceuticals Inc is a biopharmaceutical company engaged in the development and commercialization of therapies to address high unmet medical needs and improve the lives of patients. Its commercial portfolio comprises three products; HETLIOZ for the treatment of Non-24-Hour Sleep-Wake Disorder (Non-24) & nighttime sleep disturbances in Smith-Magenis Syndrome (SMS); Fanapt for the treatment of schizophrenia; and PONVORY. Its other products include VHX-896, ASO Molecules, VQW-765, Tradipitant, VTR-297 and VHX-896. The majority of revenue is derived from the Fanapt product sales. Geographically, the company sells its product predominantly in the United States, and also in Israel, Europe, and Canada.

About MEI Methode Electronics Inc.

Methode Electronics Inc supplier of custom-engineered solutions with sales, engineering, and manufacturing locations in North America, Europe, the Middle East, and Asia. It designs, engineers, and produces mechatronic products for Original Equipment Manufacturers (OEMs) utilizing a broad range of technologies for user interface, light-emitting diode (LED) lighting systems, power distribution, and sensor applications. The firm is organized into various business segments: Automotive, Industrial, Interface, and Medical. The Automotive segment, which generates maximum revenue, supplies electronic and electro-mechanical devices and related products to automobiles, including overhead and center consoles, hidden and ergonomic switches, insert molded components, LED-based lighting, and sensors.

Share on Social Networks: